Keifei Pharma Ozempitei 2mg / 1.3ml Compound peptide Pen
Weight Management • Appetite Control • Blood Sugar Support
Keifei Ozempitei 2mg / 1.3ml Compound Peptide Pen
Keifei Ozempitei is a compounded peptide pen formulation designed for controlled, precision dosing in advanced research applications. This 2mg / 1.3ml pen format is engineered for convenience, stability, and ease of use, making it suitable for structured laboratory and metabolic research environments.
Formulated within the GLP-1 receptor agonist category, this compound is commonly studied in relation to metabolic pathways, appetite regulation, and glucose-related research models. The pre-filled pen system allows for accurate dosing control and consistent delivery format across research settings.
Key Benefits
- GLP-1 receptor agonist compound commonly researched in metabolic studies
- May support appetite regulation and satiety-related research models
- Frequently explored in weight management and energy balance research contexts
- Pre-filled 2mg / 1.3ml pen design for precision and ease of use
- Supports controlled and consistent dosing in research applications
- Long-acting peptide profile for sustained research activity
- Stable, ready-to-use formulation designed for convenience and reliability
- Suitable for advanced laboratory and metabolic research workflows.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
